Filterable spreadsheets of vaccine effectiveness studies included in the weekly summary tables. Separate spreadsheets are available for primary series and booster dose studies.

This table summarizes the vaccine effectiveness data for COVID-19 studies conducted globally. This table is updated weekly. 

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in South Africa in 2016.

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Rwanda in 2019.

This document outlines the methods used in the VIEW-hub data collection and data update process.

These forest plots summarize available COVID-19 vaccine effectiveness against Omicron variant by vaccine and population of special interest, and for second booster dose and duration of effectiveness. These forest plots are updated weekly.

This plot summarizes the available laboratory evidence on the ability of COVID-19 vaccines to neutralize SARS-CoV-2 variants of concern.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

This document outlines the methods used in the COVID-19 vaccines effectiveness and impact studies review. 

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Afghanistan in 2015.